Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
107.58
+2.55 (2.43%)
At close: Feb 11, 2026, 4:00 PM EST
106.97
-0.61 (-0.57%)
After-hours: Feb 11, 2026, 7:15 PM EST
Guardant Health Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$446,595
Profits / Employee
-$197,323
Market Cap
13.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2,021 | 242 | 13.60% | 1,999 | 22 |
| Dec 31, 2023 | 1,779 | -14 | -0.78% | 1,768 | 11 |
| Dec 31, 2022 | 1,793 | 420 | 30.59% | 1,793 | 0 |
| Dec 31, 2021 | 1,373 | 509 | 58.91% | 1,373 | 0 |
| Dec 31, 2020 | 864 | 242 | 38.91% | 864 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 70,000 |
| Quest Diagnostics | 56,000 |
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 20,100 |
| Mettler-Toledo International | 18,100 |
| Revvity | 11,000 |
| Illumina | 10,370 |
| Waters | 7,600 |
GH News
- 8 days ago - Guardant Health to Participate in Upcoming Investor Conferences - Business Wire
- 9 days ago - Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions - Business Wire
- 13 days ago - Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 - Business Wire
- 13 days ago - Alger Small Cap Focus Fund Q4 2025 Portfolio Update - Seeking Alpha
- 16 days ago - Guardant Health: Look For Explosive Revenue Growth Ahead - Seeking Alpha
- 16 days ago - Alger Small Cap Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 19 days ago - Artisan Small Cap Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 20 days ago - FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer - Benzinga